Teva Archives - Page 5 of 11 -

Lilly pushes into migraine market as Emgality approved in US

https://pharmaphorum.com/news/lilly-pushes-into-migraine-market-as-emgality-approved-in-us/

FDA approves Teva’s migraine drug, decision due on Lilly’s rival

https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/

Teva holding off launch of opioid addiction drug

https://pharmaphorum.com/news/teva-holding-off-launch-of-opioid-addiction-drug/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Concerns over Teva migraine drug because of manufacturing issues

https://pharmaphorum.com/news/concerns-over-teva-migraine-drug-because-of-manufacturing-issues/

Remote HCP engagement – still a struggle for life science companies

https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/

Novartis/Amgen migraine jab works in tough-to-treat patients

https://pharmaphorum.com/news/novartis-amgen-migraine-jab-works-tough-treat-patients/

FDA rejects Teva/Celltrion biosimilars

https://pharmaphorum.com/news/fda-rejects-teva-celltrion-biosimilars/

Sosei see Teva pipeline cull as an opportunity

https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/

Search